You can read more of our “PEER” research group’s findings on polygenic embryo screening here:
polygenicembryo.org
@shaicarmi.bsky.social
@toddlencz.bsky.social

Full survey results (open-access) in NPJ Genomic Medicine:

www.nature.com/articles/s41...

85–77% of clinicians were very or extremely concerned with:
• False expectations about the future child
• Low accuracy of genetic estimates for conditions/traits
• Promoting eugenic thinking/practices
• Confusion over how to interpret the test results and use the information

Clinicians were evenly split on whether PES should be allowed or not (44% vs. 45%).

Overall caution was clear: 58% said risks outweigh benefits, while 16% said benefits outweigh risks.

Across specific scenarios, clinicians (REIs) drew a sharp distinction between health-related (e.g., cancer risk) and trait-based (e.g., IQ) uses of PES:
• 59% approved of health-related embryo selection
• 6% approved of behavioral trait-based selection

Clinicians (n=144) showed low overall approval of people using polygenic embryo screening:

• 12% approved.
• 42% neither approved nor disapproved.
• 46% disapproved.

Read about our findings on public perceptions of neurotechnoloigies in this
@MGBResearchNews
research highlight: massgeneralbrigham.org/en/about/new...

Participants also rated each technology on:
🔹Perceived benefit
🔹Acceptability
🔹Likelihood of using it themselves
🔹Invasiveness
🔹Risk
🔹Perceived change to the person

Would you consider using these neurotechnologies if you were experiencing severe mood, memory, or motor symptoms?

Here’s how 1000+ U.S participants responded when asked that exact question.

Participants were then presented with 4 neurotechnologies:
🔹 Deep Brain Stimulation (DBS)
🔹 MRI-guided Focused Ultrasound (MRgFUS)
🔹 Pills
🔹 Transcranial Magnetic Stimulation (TMS)

1000+ Participants were randomly assigned to read about a person experiencing one of three types of symptoms:

🔹Mood symptoms
🔹Memory symptoms
🔹Motor symptoms